About Mosanna Therapeutics
Mosanna Therapeutics is a company based in Basel (Switzerland) founded in 2022 by Jonathan Talbot.. Mosanna Therapeutics has raised $80 million across 3 funding rounds from investors including EQT, Norwest Venture Partners and Supermoon Capital. Mosanna Therapeutics offers products and services including MOS-118. Mosanna Therapeutics operates in a competitive market with competitors including Apnimed, Aculys, Avadel Pharmaceuticals, Circadian Therapeutics and sofi, among others.
- Headquarter Basel, Switzerland
- Founders Jonathan Talbot
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Mosanna Therapeutics Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$80 M (USD)
in 3 rounds
-
Latest Funding Round
$80 M (USD), Series A
Jun 09, 2025
-
Investors
EQT
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mosanna Therapeutics
Mosanna Therapeutics offers a comprehensive portfolio of products and services, including MOS-118. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small molecule for treating metabolic obstructive sleep apnea.
Unlock access to complete
Product Management Team
1 people
Leadership Team
1 people
Consultant Team
1 people
CSO Team
1 people
Unlock access to complete
Funding Insights of Mosanna Therapeutics
Mosanna Therapeutics has successfully raised a total of $80M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $80 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $80.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Series A - Mosanna Therapeutics | Valuation | EQT , Pivotal Life Sciences | |
| Apr, 2023 | Amount | Seed - Mosanna Therapeutics | Valuation | Supermoon Capital , HTGF |
|
| Jul, 2022 | Amount | Seed - Mosanna Therapeutics | Valuation | Forty51 Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mosanna Therapeutics
Mosanna Therapeutics has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include EQT, Norwest Venture Partners and Supermoon Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is offered for sleep, health, and wellness innovations.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Forty51 Ventures is focused on building early-stage biotech companies in Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mosanna Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mosanna Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mosanna Therapeutics Comparisons
Competitors of Mosanna Therapeutics
Mosanna Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apnimed, Aculys, Avadel Pharmaceuticals, Circadian Therapeutics and sofi, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for obstructive sleep apnea are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic medicines for neuropsychiatric and sleep disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proprietary drug delivery technologies and narcolepsy treatments are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat circadian rhythm disruption
|
|
| domain | founded_year | HQ Location |
Provider of natural remedy based mental & physical wellbeing services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mosanna Therapeutics
Frequently Asked Questions about Mosanna Therapeutics
When was Mosanna Therapeutics founded?
Mosanna Therapeutics was founded in 2022.
Where is Mosanna Therapeutics located?
Mosanna Therapeutics is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Who is the current CEO of Mosanna Therapeutics?
Jonathan Talbot is the current CEO of Mosanna Therapeutics. They have also founded this company.
Is Mosanna Therapeutics a funded company?
Mosanna Therapeutics is a funded company, having raised a total of $80M across 3 funding rounds to date.
What does Mosanna Therapeutics do?
Mosanna Therapeutics was founded in 2022 in Basel, Switzerland, within the biotechnology sector. Small molecule therapeutics targeting sleep apnea are developed, with a focus on obstructive sleep apneas cardiometabolic effects. The lead candidate, MOS-118, is positioned as a precision medicine. Operations emphasize research and development of these compounds, led by co-founder and CEO Jonathan Talbot. The companys domain is mosanna.com.
Who are the top competitors of Mosanna Therapeutics?
Mosanna Therapeutics's top competitors include Apnimed, Avadel Pharmaceuticals and Aculys.
What products or services does Mosanna Therapeutics offer?
Mosanna Therapeutics offers MOS-118.
Who are Mosanna Therapeutics's investors?
Mosanna Therapeutics has 8 investors. Key investors include EQT, Norwest Venture Partners, Supermoon Capital, High-Tech Gründerfonds, and Forty51 Ventures.